reported that the diagnostic sensitivity and specificity could reach 88.5% and 82%, respectively, combined with six hematological tumor markers (CA153, CEA, CYFRA21- 1, NSE, Pro-GRP, and SCC) (36). This evidence concerns the gene GRP and neoplasm.